Cluster model analysis of late rectal bleeding after IMRT of prostate cancer: a case-control study

International Journal of Radiation Oncology, Biology, Physics
Susan L TuckerHoward D Thames

Abstract

Cluster models are newly developed normal-tissue complication probability models in which the spatial aspects of radiation-induced injury are taken into account by considering the size of spatially contiguous aggregates of damaged tissue units. The purpose of this study was to test the validity of a two-dimensional cluster model of late rectal toxicity based on maximum cluster size of damage to rectal surface. A paired case-control study was performed in which each of 9 patients experiencing Grade 2 or higher late rectal toxicity after intensity-modulated radiation therapy of localized prostate cancer was paired with a patient having a similar rectal dose-surface histogram but free of rectal toxicity. Numeric simulations were performed to determine the distribution of maximum cluster size on each rectal surface for each of many different choices of possible model parameters. Model parameters were found for which patients with rectal toxicity were consistently more likely to have a significantly larger mean maximum cluster size than their matched controls. These parameter values correspond to a 50% probability of tissue-unit damage at doses near 30 Gy. This study suggests that a cluster model based on maximum cluster size of dam...Continue Reading

References

Dec 1, 1988·International Journal of Radiation Oncology, Biology, Physics·G E HanksJ J Diamond
Apr 1, 1986·International Journal of Radiation Oncology, Biology, Physics·A A PerezF Zivnuska
Jan 1, 1985·International Journal of Radiation Oncology, Biology, Physics·G E HanksS Kramer
Mar 1, 1984·International Journal of Radiation Oncology, Biology, Physics·S A LeibelS Kramer
Feb 1, 1982·International Journal of Radiation Oncology, Biology, Physics·H D ThamesG H Fletcher
Jun 15, 1995·International Journal of Radiation Oncology, Biology, Physics·T E SchultheissW R Lee
Jun 15, 1993·International Journal of Radiation Oncology, Biology, Physics·V A BenkM Goitein
Oct 1, 1996·International Journal of Radiation Oncology, Biology, Physics·A C HartfordW U Shipley
Jan 1, 1997·International Journal of Radiation Oncology, Biology, Physics·T E SchultheissG E Hanks
Feb 25, 1999·International Journal of Radiation Oncology, Biology, Physics·E DaleS D Fosså
Apr 12, 2000·International Journal of Radiation Oncology, Biology, Physics·M W SkwarchukC C Ling
Sep 7, 2000·International Journal of Radiation Oncology, Biology, Physics·A PollackA C von Eschenbach
Oct 6, 2000·International Journal of Radiation Oncology, Biology, Physics·M R StoreyI Rosen
Feb 15, 2001·International Journal of Radiation Oncology, Biology, Physics·A JacksonC C Ling
Apr 11, 2001·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·S WachterR Pötter
Nov 13, 2001·International Journal of Radiation Oncology, Biology, Physics·UNKNOWN Intensity Modulated Radiation Therapy Collaborative Working Group
Jul 20, 2002·International Journal of Radiation Oncology, Biology, Physics·Alan PollackIsaac Rosen
Sep 5, 2002·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Claudio FiorinoAnna Piazzolla
Dec 3, 2002·International Journal of Radiation Oncology, Biology, Physics·Eugene H HuangDeborah A Kuban
Jul 23, 2003·International Journal of Radiation Oncology, Biology, Physics·Rex CheungDeborah Kuban
Oct 25, 2003·International Journal of Radiation Oncology, Biology, Physics·Claudio FiorinoRiccardo Valdagni
Dec 4, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Dirk VordermarkOliver Koelbl
Dec 4, 2003·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Carlo GrecoRoberto Orecchia
Mar 6, 2004·International Journal of Radiation Oncology, Biology, Physics·Peter C M KoperPeter Levendag
Mar 31, 2004·International Journal of Radiation Oncology, Biology, Physics·Rex CheungDeborah Kuban
May 18, 2004·International Journal of Radiation Oncology, Biology, Physics·Susan L TuckerRadhe Mohan
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Almudena ZapateroArmando Pérez-Torrubia
Jul 28, 2004·International Journal of Radiation Oncology, Biology, Physics·Howard D ThamesRadhe Mohan
Nov 3, 2004·International Journal of Radiation Oncology, Biology, Physics·David J Brenner
Dec 14, 2004·International Journal of Radiation Oncology, Biology, Physics·Susan L TuckerDeborah Kuban
Mar 9, 2005·International Journal of Radiation Oncology, Biology, Physics·Rex CheungDeborah Kuban

❮ Previous
Next ❯

Citations

Jun 10, 2009·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Raffaella CambriaRoberto Orecchia
Sep 13, 2013·Der Urologe. Ausg. A·S E Combs, J Debus
Jun 30, 2007·The Journal of Pharmacology and Experimental Therapeutics·Sandra ClaroRaouf Ali Khalil
Mar 26, 2013·American Journal of Respiratory Cell and Molecular Biology·Biji MathewJoe G N Garcia
Apr 24, 2012·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Florian BuettnerMike Partridge
Oct 19, 2010·International Journal of Radiation Oncology, Biology, Physics·Robert Jan SmeenkJohannes H A M Kaanders
May 11, 2010·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Robert Jan SmeenkJohannes H A M Kaanders
Dec 13, 2006·International Journal of Radiation Oncology, Biology, Physics·Emile N J Th van LinAndries G Visser
Aug 8, 2015·The British Journal of Radiology·Lynsey J HamlettAdam H Aitkenhead
Aug 30, 2011·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Robert Jan SmeenkJohannes H A M Kaanders
Nov 4, 2016·Medical Physics·A WitztumM A Hawkins
Aug 8, 2009·Physics in Medicine and Biology·Florian BuettnerMike Partridge
Mar 23, 2010·Physics in Medicine and Biology·Eva RutkowskaAlan Nahum
Jul 13, 2019·Acta Oncologica·Eva OnjukkaTiziana Rancati
Jun 13, 2013·Physics in Medicine and Biology·Jiazhou WangYing Xiao
Jan 23, 2013·Physics in Medicine and Biology·Leonid Hanin, Marco Zaider
Aug 14, 2018·Frontiers in Oncology·Huan-Hsin TsengIssam El Naqa
Mar 10, 2011·Physics in Medicine and Biology·Florian BuettnerMike Partridge
May 29, 2021·Physics in Medicine and Biology·Martin A EbertClaudio Fiorino

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.